Cargando…

Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials

Detalles Bibliográficos
Autores principales: Shankar-Hari, Manu, Estcourt, Lise, Harvala, Heli, Roberts, David, Menon, David K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370253/
https://www.ncbi.nlm.nih.gov/pubmed/32690059
http://dx.doi.org/10.1186/s13054-020-03163-3
_version_ 1783560952062410752
author Shankar-Hari, Manu
Estcourt, Lise
Harvala, Heli
Roberts, David
Menon, David K.
author_facet Shankar-Hari, Manu
Estcourt, Lise
Harvala, Heli
Roberts, David
Menon, David K.
author_sort Shankar-Hari, Manu
collection PubMed
description
format Online
Article
Text
id pubmed-7370253
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73702532020-07-20 Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials Shankar-Hari, Manu Estcourt, Lise Harvala, Heli Roberts, David Menon, David K. Crit Care Editorial BioMed Central 2020-07-20 /pmc/articles/PMC7370253/ /pubmed/32690059 http://dx.doi.org/10.1186/s13054-020-03163-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Editorial
Shankar-Hari, Manu
Estcourt, Lise
Harvala, Heli
Roberts, David
Menon, David K.
Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials
title Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials
title_full Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials
title_fullStr Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials
title_full_unstemmed Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials
title_short Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials
title_sort convalescent plasma to treat critically ill patients with covid-19: framing the need for randomised clinical trials
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370253/
https://www.ncbi.nlm.nih.gov/pubmed/32690059
http://dx.doi.org/10.1186/s13054-020-03163-3
work_keys_str_mv AT shankarharimanu convalescentplasmatotreatcriticallyillpatientswithcovid19framingtheneedforrandomisedclinicaltrials
AT estcourtlise convalescentplasmatotreatcriticallyillpatientswithcovid19framingtheneedforrandomisedclinicaltrials
AT harvalaheli convalescentplasmatotreatcriticallyillpatientswithcovid19framingtheneedforrandomisedclinicaltrials
AT robertsdavid convalescentplasmatotreatcriticallyillpatientswithcovid19framingtheneedforrandomisedclinicaltrials
AT menondavidk convalescentplasmatotreatcriticallyillpatientswithcovid19framingtheneedforrandomisedclinicaltrials
AT convalescentplasmatotreatcriticallyillpatientswithcovid19framingtheneedforrandomisedclinicaltrials